ArticleCell death & disease2022

Long-term oral administration of an HNF4α agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function.

Vimal Veeriah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.